Surgical site infections after cesarean delivery: epidemiology, prevention and treatment

Tetsuya Kawakita, Helain J Landy, Tetsuya Kawakita, Helain J Landy

Abstract

Cesarean delivery (CD) is one of the most common procedures performed in the United States, accounting for 32% of all deliveries. Postpartum surgical site infection (SSI), wound infection and endometritis is a major cause of prolonged hospital stay and poses a burden to the health care system. SSIs complicate a significant number of patients who undergo CD - 2-7% will experience sound infections and 2-16% will develop endometritis. Many risk factors for SSI have been described. These include maternal factors (such as tobacco use; limited prenatal care; obesity; corticosteroid use; nulliparity; twin gestations; and previous CD), intrapartum and operative factors (such as chorioamnionitis; premature rupture of membranes; prolonged rupture of membranes; prolonged labor, particularly prolonged second stage; large incision length; subcutaneous tissue thickness > 3 cm; subcutaneous hematoma; lack of antibiotic prophylaxis; emergency delivery; and excessive blood loss), and obstetrical care on the teaching service of an academic institution. Effective interventions to decrease surgical site infection include prophylactic antibiotic use (preoperative first generation cephalosporin and intravenous azithromycin), chlorhexidine skin preparation instead of iodine, hair removal using clippers instead of razors, vaginal cleansing by povidone-iodine, placental removal by traction of the umbilical cord instead of by manual removal, suture closure of subcutaneous tissue if the wound thickness is >2 cm, and skin closure with sutures instead of with staples. Implementation of surgical bundles in non-obstetric patients has been promising., Creating a similar patient care bundle comprised evidence-based elements in patients who undergo CD may decrease the incidence of this major complication. Each hospital has the opportunity to create its own CD surgical bundle to decrease surgical site infection.

Keywords: Cesarean delivery; Chlorhexidine skin preparation; Surgical bundle; Surgical site infection; Vaginal cleansing.

References

    1. Hamilton BE, Martin JA, Osterman MJK, et al. Births: final data for 2014. National vital statistics reports; vol 64 no 12. Hyattsville: National Center for Health Statistics; 2015.
    1. Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107(6):1226–1232. doi: 10.1097/01.AOG.0000219750.79480.84.
    1. Liu S, Liston RM, Joseph KS, et al. Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ. 2007;176(4):455–460. doi: 10.1503/cmaj.060870.
    1. Deneux-Tharaux C, Carmona E, Bouvier-Colle MH, et al. Postpartum maternal mortality and cesarean delivery. Obstet Gynecol. 2006;108(3 Pt 1):541–548. doi: 10.1097/01.AOG.0000233154.62729.24.
    1. Burrows LJ, Meyn LA, Weber AM. Maternal morbidity associated with vaginal versus cesarean delivery. Obstet Gynecol. 2004;103:907–912. doi: 10.1097/01.AOG.0000124568.71597.ce.
    1. Mackeen AD, Khalifeh A, Fleisher J, et al. Suture compared with staple skin closure after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2014;123(6):1169–1175. doi: 10.1097/AOG.0000000000000227.
    1. Peleg D, Eberstark E, Warsof SL, et al. Early wound dressing removal after scheduled cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol. 2016;215(3):388.e1–388.e5. doi: 10.1016/j.ajog.2016.03.035.
    1. Olsen MA, Butler AM, Willers DM, et al. Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol. 2008;29(6):477–484. doi: 10.1086/587810.
    1. Tita AT, Szychowski JM, Boggess K, et al. Adjunctive Azithromycin prophylaxis for cesarean delivery. N Engl J Med. 2016;375(13):1231–1241. doi: 10.1056/NEJMoa1602044.
    1. Haas DM, Pazouki F, Smith RR, et al. Vaginal cleansing before cesarean delivery to reduce postoperative infectious morbidity: a randomized, controlled trial. Am J Obstet Gynecol. 2010;202(3):310.e1–310.e6. doi: 10.1016/j.ajog.2010.01.005.
    1. Costantine MM, Rahman M, Ghulmiyah L, et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol. 2008;199(3):301.e1–301.e6. doi: 10.1016/j.ajog.2008.06.077.
    1. Blumenfeld YJ, El-Sayed YY, Lyell DJ, et al. Risk factors for prolonged postpartum length of stay following cesarean delivery. Am J Perinatol. 2015;32(9):825–832. doi: 10.1055/s-0034-1543953.
    1. Martens MG, Kolrud BL, Faro S, et al. Development of wound infection or separation after cesarean delivery. Prospective evaluation of 2,431 cases. J Reprod Med. 1995;40:171–175.
    1. Roberts S, Maccato M, Faro S, Pinell P. The microbiology of post-cesarean wound morbidity. Obstet Gynecol. 1993;81:383–386.
    1. Goepfert AR, Guinn DA, Andrews WW, et al. Necrotizing fasciitis after cesarean delivery. Obstet Gynecol. 1997;89(3):409–412. doi: 10.1016/S0029-7844(96)00511-X.
    1. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147–159. doi: 10.1093/cid/ciu444.
    1. Sudarsky LA, Laschinger JC, Coppa GF, et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg. 1987;206(5):661. doi: 10.1097/00000658-198711000-00018.
    1. Fitzwater JL, Tita AT. Prevention and management of cesarean wound infection. Obstet Gynecol Clin N Am. 2014;41(4):671–689. doi: 10.1016/j.ogc.2014.08.008.
    1. Rosene K, Eschenbach DA, Tompkins LS, et al. Polymicrobial early postpartum endometritis with facultative and anaerobic bacteria, genital mycoplasmas, and Chlamydia trachomatis: treatment with piperacillin or cefoxitin. J Infect Dis. 1986;153(6):1028. doi: 10.1093/infdis/153.6.1028.
    1. Reid VC, Hartmann KE, McMahon M, et al. Vaginal preparation with povidone iodine and postcesarean infectious morbidity: a randomized controlled trial. Obstet Gynecol. 2001;97:147–152.
    1. Guzman MA, Prien SD, Blann DW. Post-cesarean related infection and vaginal preparation with povidone-iodine revisited. Primary Care Update OB/GYNS. 2002;9(6):206–209. doi: 10.1016/S1068-607X(02)00119-1.
    1. Tran TS, Jamulitrat S, Chongsuvivatwong V, et al. Risk factors for postcesarean surgical site infection. Obstet Gynecol. 2000;95(3):367–371.
    1. Avila C, Bhangoo R, Figueroa R, et al. Association of smoking with wound complications after cesarean delivery. J Matern Fetal Neonatal Med. 2012;25:1250–1253. doi: 10.3109/14767058.2011.636462.
    1. Jama FE. Risk factors for wound infection after lower segment cesarean section. Qatar Med J. 2012;2:26–31.
    1. De Vivo A, Mancuso A, Giacobbe A, et al. Wound length and corticosteroid administration as risk factors for surgical-site complications following cesarean section. Acta Obstet Gynecol Scand. 2010;89(3):355–359. doi: 10.3109/00016340903568175.
    1. Killian CA, Graffunder EM, Vinciguerra TJ, et al. Risk factors for surgical-site infections following cesarean section. Infect Control Hosp Epidemiol. 2001;22:613–617. doi: 10.1086/501831.
    1. Wloch C, Wilson J, Lamagni T, et al. Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG. 2012;119(11):1324–1333. doi: 10.1111/j.1471-0528.2012.03452.x.
    1. Opøien HK, Valbø A, Grinde-Andersen A, et al. Post-cesarean surgical site infections according to CDC standards: rates and risk factors. A prospective cohort study. Acta Obstet Gynecol Scand. 2007;86(9):1097–1102. doi: 10.1080/00016340701515225.
    1. Schneid-Kofman N, Sheiner E, Levy A, et al. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet. 2005;90:10–15. doi: 10.1016/j.ijgo.2005.03.020.
    1. Vermillion ST, Lamoutte C, Soper DE, et al. Wound infection after cesarean: effect of subcutaneous tissue thickness. Obstet Gynecol. 2000;95(6 Pt 1):923–926.
    1. Tuuli MG, Liu L, Longman RE, et al. Infectious morbidity is higher after second-stage compared with first-stage cesareans. Am J Obstet Gynecol. 2014;211(4):410.e1–410.e6. doi: 10.1016/j.ajog.2014.03.040.
    1. Takoudes TC, Weitzen S, Slocum J, et al. Risk of cesarean wound complications in diabetic gestations. Am J Obstet Gynecol. 2004;191(3):958–963. doi: 10.1016/j.ajog.2004.05.063.
    1. Chaim W, Bashiri A, Bar-David J, et al. Prevalence and clinical significance of postpartum endometritis and wound infection. Infect Dis Obstet Gynecol. 2000;8:77–82. doi: 10.1155/S1064744900000053.
    1. Olsen MA, Butler AM, Willers DM, et al. Comparison of costs of surgical site infection and endometritis after cesarean delivery using claims and medical record data. Infect Control Hosp Epidemiol. 2010;31:872–875. doi: 10.1086/655435.
    1. Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database of Systematic Reviews 2014, Issue 10. Art. No.: CD007482.
    1. Sullivan SA, Smith T, Chang E, et al. Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity: a randomized, controlled trial. Am J Obstet Gynecol. 2007;196:455.e1–455.e5. doi: 10.1016/j.ajog.2007.03.022.
    1. Thigpen BD, Hood WA, Chauhan S, et al. Timing of prophylactic antibiotic administration in the uninfected laboring gravida: a randomized clinical trial. Am J Obstet Gynecol. 2005;192:1864–1871. doi: 10.1016/j.ajog.2004.12.063.
    1. Wax JR, Hersey K, Philput C, et al. Single dose cefazolin prophylaxis for postcesarean infections: before vs after cord clamping. J Matern Fetal Med. 1997;6:61–65.
    1. Owens SM, Brozanski BS, Meyn LA, et al. Antimicrobial prophylaxis for cesarean delivery before skin incision. Obstet Gynecol. 2009;114(3):573–579. doi: 10.1097/AOG.0b013e3181b490f1.
    1. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 120: use of prophylactic antibiotics in labor and delivery. Obstet Gynecol. 2011;117(6):1472–1483. doi: 10.1097/AOG.0b013e3182238c31.
    1. Ahmadzia HK, Patel EM, Joshi D, et al. Obstetric surgical site infections: 2 grams compared with 3 grams of Cefazolin in morbidly obese women. Obstet Gynecol. 2015;126(4):708–715. doi: 10.1097/AOG.0000000000001064.
    1. Tita AT, Hauth JC, Grimes A, et al. Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis. Obstet Gynecol. 2008;111(1):51–56. doi: 10.1097/01.AOG.0000295868.43851.39.
    1. Tuuli MG, Liu J, Stout MJ, et al. A randomized trial comparing skin antiseptic agents at cesarean delivery. N Engl J Med. 2016;374(7):647–655. doi: 10.1056/NEJMoa1511048.
    1. Ngai IM, Van Arsdale A, Govindappagari S, et al. Skin preparation for prevention of surgical site infection after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2015;126(6):1251–1257. doi: 10.1097/AOG.0000000000001118.
    1. Tanner J, Norrie P, Melen K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev. 2011;(11):CD004122.
    1. Ahmed MR, Aref NK, Sayed Ahmed WA, et al. Chlorhexidine vaginal wipes prior to elective cesarean section: does it reduce infectious morbidity? A randomized trial. J Matern Fetal Neonatal Med. 2016;1:1–4.
    1. Yildirim G, Güngördük K, Asicioğlu O, et al. Does vaginal preparation with povidone-iodine prior to caesarean delivery reduce the risk of endometritis? A randomized controlled trial. J Matern Fetal Neonatal Med. 2012;25(11):2316–2321. doi: 10.3109/14767058.2012.693994.
    1. Haas DM, Morgan S, Contreras K. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev. 2014;(9):CD007892.
    1. American College of Obstetricians and Gynecologists Women's Health Care Physicians. Committee on Gynecologic Practice Committee opinion no. 571: solutions for surgical preparation of the vagina. Obstet Gynecol. 2013;122(3):718–720. doi: 10.1097/01.AOG.0000433982.36184.95.
    1. Walsh CA, Walsh SR. Extraabdominal vs intraabdominal uterine repair at cesarean delivery: a metaanalysis. Am J Obstet Gynecol. 2009;200(6):625.e1–625.e8. doi: 10.1016/j.ajog.2009.01.009.
    1. Anorlu RI, Maholwana B, Hofmeyr GJ. Methods of delivering the placenta at caesarean section. Cochrane Database Syst Rev. 2008;(3):CD004737.
    1. Atkinson MW, Owen J, Wren A, et al. The effect of manual removal of the placenta on post-cesarean endometritis. Obstet Gynecol. 1996;87(1):99–102. doi: 10.1016/0029-7844(95)00359-2.
    1. Viney R, Isaacs C, Chelmow D. Intraabdominal irrigation at cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2012;120:708. doi: 10.1097/AOG.0b013e3182677689.
    1. Harrigill KM, Miller HS, Haynes DE. The effect of intraabdominal irrigation at cesarean delivery on maternal morbidity: a randomized trial. Obstet Gynecol. 2003;101(1):80–85.
    1. Chelmow D, Rodriguez EJ, Sabatini MM. Suture closure of subcutaneous fat and wound disruption after cesarean delivery: a meta-analysis. Obstet Gynecol. 2004;103(5 Pt 1):974–980. doi: 10.1097/01.AOG.0000124807.76451.47.
    1. Ramsey PS, White AM, Guinn DA, et al. Subcutaneous tissue reapproximation, alone or in combination with drain, in obese women undergoing cesarean delivery. Obstet Gynecol. 2005;105(5 Pt 1):967–973. doi: 10.1097/01.AOG.0000158866.68311.d1.
    1. Hellums EK, Lin MG, Ramsey PS. Prophylactic subcutaneous drainage for prevention of wound complications after cesarean delivery--a metaanalysis. Am J Obstet Gynecol. 2007;197(3):229–235. doi: 10.1016/j.ajog.2007.05.023.
    1. Tuuli MG, Rampersad RM, Carbone JF, et al. Staples compared with subcuticular suture for skin closure after cesarean delivery: a systematic review and meta-analysis. Obstet Gynecol. 2011;117(3):682–690. doi: 10.1097/AOG.0b013e31820ad61e.
    1. Mackeen AD, Berghella V, Larsen ML. Techniques and materials for skin closure in caesarean section. Cochrane Database Syst Rev. 2012;11:CD003577.
    1. Ubbink DT, Westerbos SJ, Evans D, et al. Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001898.
    1. Swift SH, Zimmerman MB, Hardy-Fairbanks AJ. Effect of single-use negative pressure wound therapy on Postcesarean infections and wound complications for high-risk patients. J Reprod Med. 2015;60(5-6):211–218.
    1. Mark KS, Alger L, Terplan M. Incisional negative pressure therapy to prevent wound complications following cesarean section in morbidly obese women: a pilot study. Surg Innov. 2014;21(4):345–349. doi: 10.1177/1553350613503736.
    1. Echebiri NC, McDoom MM, Aalto MM, et al. Prophylactic use of negative pressure wound therapy after cesarean delivery. Obstet Gynecol. 2015;125(2):299–307. doi: 10.1097/AOG.0000000000000634.
    1. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital infection Control practices advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250–278. doi: 10.1086/501620.
    1. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013;368(6):533–542. doi: 10.1056/NEJMoa1113849.
    1. Johnson MP, Kim SJ, Langstraat CL, et al. Using bundled interventions to reduce surgical site infection after major gynecologic cancer surgery. Obstet Gynecol. 2016;127(6):1135–1144. doi: 10.1097/AOG.0000000000001449.
    1. Keenan JE, Speicher PJ, Thacker JK, et al. The preventive surgical site infection bundle in colorectal surgery: an effective approach to surgical site infection reduction and health care cost savings. JAMA Surg. 2014;149(10):1045–1052. doi: 10.1001/jamasurg.2014.346.
    1. Cima R, Dankbar E, Lovely J, et al. Colorectal surgery surgical site infection reduction program: a national surgical quality improvement program--driven multidisciplinary single-institution experience. J Am Coll Surg. 2013;216(1):23–33. doi: 10.1016/j.jamcollsurg.2012.09.009.
    1. Doherty GM. Chapter 5. Postoperative complications. In: Doherty GM, editor. CURRENT Diagnosis & Treatment: surgery, 13e. New York: McGraw-Hill; 2010.
    1. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-Resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666. doi: 10.1056/NEJMoa055356.
    1. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18. doi: 10.1093/cid/ciq146.
    1. Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am J Surg. 1998;176:39S–347. doi: 10.1016/S0002-9610(98)00184-6.
    1. Ovington LGS. Hanging wet-to-dry dressings out to dry. Home Healthc Nurse. 2001;19(8):477. doi: 10.1097/00004045-200108000-00007.
    1. Vermeulen H, Ubbink D, Goossens A, et al. Dressings and topical agents for surgical wounds healing by secondary intention. Cochrane Database Syst Rev 2004;(2):CD003554.
    1. Wechter ME, Pearlman MD, Hartmann KE. Reclosure of the disrupted laparotomy wound: a systematic review. Obstet Gynecol. 2005;106:376–383. doi: 10.1097/01.AOG.0000171114.75338.06.
    1. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147–159. doi: 10.1093/cid/ciu444.
    1. Darenberg J, Ihendyane N, Sjölin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37(3):333–340. doi: 10.1086/376630.
    1. Stevens DL, Laine BM, Mitten JE. Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens. Antimicrob Agents Chemother. 1987;31:312–316. doi: 10.1128/AAC.31.2.312.
    1. Mackeen AD, Packard RE, Ota E, et al. Antibiotic regimens for postpartum endometritis. Cochrane Database Syst Rev 2015:CD001067.
    1. Mitra AG, Whitten MK, Laurent SL, et al. A randomized, prospective study comparing once-daily gentamicin versus thrice-daily gentamicin in the treatment of puerperal infection. Am J Obstet Gynecol. 1997;177(4):786. doi: 10.1016/S0002-9378(97)70269-2.
    1. Del Priore G, Jackson-Stone M, Shim EK, et al. A comparison of once-daily and 8-hour gentamicin dosing in the treatment of postpartum endometritis. Obstet Gynecol. 1996;87(6):994. doi: 10.1016/0029-7844(96)00054-3.
    1. Livingston JC, Llata E, Rinehart E, et al. Gentamicin and clindamycin therapy in postpartum endometritis: the efficacy of daily dosing versus dosing every 8 hours. Am J Obstet Gynecol. 2003;188(1):149. doi: 10.1067/mob.2003.88.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe